Pharmacogenomic Effect/ADR for Thioridazine (DBSNPE004877)

Identifier
DBSNPE004877
Drug
Thioridazine (DB00679)
Interacting Gene/Enzyme
Cytochrome P450 2D6
Gene Name
CYP2D6
UniProt ID
P10635
Defining Change(s)
1720A>CNot Available
Allele Name
CYP2D6*50
Genotype(s)
Not Available
Type(s)
ADR Inferred
Groups
Decreased CYP2D6
Description
Reduced CYP2D6 activity associated with Torsades de pointes and/or sudden death.
References
  1. Thioridazine Hydrochloride[package insert]. Morgantown, West Virginia: MYLAN PHARMACEUTICALS INC.; 2016. [Link]